Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7026654 | 0.78 | PTGER3 (0.50) | GABRA1GABRB2KDM4EMAPTHTT | |
| SCHEMBL2141001 | 0.76 | GABRA1 (0.44) | GABRA1GABRB2KDM4EMEN1KMT2A | |
| SCHEMBL7219053 | 0.76 | GABRA1 (0.47) | GABRA1GABRB2KDM4EMEN1KMT2A | |
| SCHEMBL345322 | 0.76 | KDM4E (0.40) | GABRA1GABRB2KDM4EMEN1KMT2A | |
| SCHEMBL28730777 | 0.74 | LMNA (0.50) | LMNAMAPT | |
| SCHEMBL2361001 | 0.73 | GABRA1 (0.46) | GABRA1GABRB2KDM4EMEN1KMT2A | |
| SCHEMBL18136 | 0.73 | GABRA1 (0.56) | GABRA1GABRB2KDM4EMEN1KMT2A | |
| SCHEMBL21462042 | 0.73 | GABRA1 (0.48) | GABRA1GABRB2KDM4EMEN1KMT2A | |
| SCHEMBL5683687 | 0.71 | GABRA1 (0.43) | GABRA1GABRB2KDM4EKMT2AALDH1A1 | |
| SCHEMBL3297839 | 0.71 | NFE2L2 (0.42) | GABRA1GABRB2KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080131381-A1 | METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM | MERCK PATENT GESELLSCHAFT (DE) | 2008-06-05 | — | — | US | claimed |
| US-5670140-A | SKIN PROTECTION FOR COSMETICS FOR RADIATION RESISTANCE | L'OREAL (FR) | 1997-09-23 | — | — | US | claimed |
| US-5624663-A | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates | L'OREAL (FR) | 1997-04-29 | — | — | US | claimed |
| EP-0551510-B1 | PHOTOSTABLE FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND A 4-METHOXY BENZYLIDENE CYANOACETATE | OREAL (FR) | 1995-09-27 | — | — | EP | claimed |
| EP-0601080-B1 | FILTERING COSMETIC COMPOSITION CONTAINING A LIPOSOLUBLE FILTER POLYMER WITH HYDROCARBONATED STRUCTURE AND A FILTER SILICONE | OREAL (FR) | 1995-07-26 | — | — | EP | claimed |
| EP-0551510-A1 | PHOTOSTABLE FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND A 4-METHOXY BENZYLIDENE CYANOACETATE. | OREAL (FR) | 1993-07-21 | — | — | EP | claimed |
| WO-1993002659-A1 | PHOTOSTABLE FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND A 4-METHOXY BENZYLIDENE CYANOACETATE | L'OREAL (FR) | 1993-02-18 | — | — | WO | claimed |
| US-12011496-B2 | Topical macqui berry formulation | Tracie Martyn International, Inc. (US) | 2024-06-18 | — | — | US | disclosed |
| US-10993897-B2 | Topical macqui berry formula | Tracie Martyn International, Inc. (US) | 2021-05-04 | — | — | US | disclosed |
| US-20190151227-A1 | TOPICAL MACQUI BERRY FORMULA | TRACIE MARTYN INT INC (US) | 2019-05-23 | — | — | US | disclosed |
| EP-2451427-B1 | UV FILTER COMBINATIONS COMPRISING BENZYLIDENE MALONATES | BASF SE (DE) | 2018-04-25 | — | — | EP | disclosed |
| US-20170027853-A1 | TOPICAL MACQUI BERRY FORMULATION | TRACIE MARTYN INTERNATIONAL, LLC | 2017-02-02 | — | — | US | disclosed |
| US-9463153-B2 | Topical macqui berry formulation | Trade Martyn International, LLC (US) | 2016-10-11 | — | — | US | disclosed |
| US-5670140-A | SKIN PROTECTION FOR COSMETICS FOR RADIATION RESISTANCE | L'OREAL (FR) | 1997-09-23 | — | — | US | disclosed |
| US-5670140-A | SKIN PROTECTION FOR COSMETICS FOR RADIATION RESISTANCE | L'OREAL (FR) | 1997-09-23 | — | — | US | disclosed |
| US-5670140-A | SKIN PROTECTION FOR COSMETICS FOR RADIATION RESISTANCE | L'OREAL (FR) | 1997-09-23 | — | — | US | disclosed |
| US-5624663-A | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates | L'OREAL (FR) | 1997-04-29 | — | — | US | disclosed |
| US-5624663-A | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates | L'OREAL (FR) | 1997-04-29 | — | — | US | disclosed |
| US-5624663-A | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates | L'OREAL (FR) | 1997-04-29 | — | — | US | disclosed |
| EP-0551510-B1 | PHOTOSTABLE FILTERING COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND A 4-METHOXY BENZYLIDENE CYANOACETATE | OREAL (FR) | 1995-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080131381-A1 | METHODS FOR PHOTOSTABILIZING INGREDIENTS WITHIN COSMETICS, PERSONAL CARE AND HOUSEHOLD PRODUCTS AND COMPOSITIONS OBTAINED THEREFROM | TYR, NISCH, PPOX | GABRA1 4387/4885GABRB2 4689/4885KDM4E 2860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.